University Of Nairobi

This study looks at people with HIV whose virus has become resistant to the drug dolutegravir. It compares two options: staying on dolutegravir or switching to another drug called darunavir boosted by ritonavir. The goal is to see which approach better controls the virus. About 3…

This study looks at 6,600 people with HIV whose current medication (dolutegravir) is not fully working. Instead of switching drugs right away, researchers want to see if extra counseling to take medicine correctly can help suppress the virus. They also track how drug resistance d…